110026-03-4|Sodium 2-((R)-4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethanesulfonate hydrate|BLD Pharm

Startseite/ Inhibitors/Agonists/ Apoptosis/ Caspase/Sodium 2-((R)-4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethanesulfonate hydrate

Sodium 2-((R)-4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethanesulfonate hydrate *Cold-chain transportation

CAS NO.： 110026-03-4

Größe	Preis	Verkaufsrabatt	Rabatt	Lager-CN	Lager-US	Lager-IND	Lager-EU	Menge

How to Order +86-21-61629022 sales@bldpharm.com tech@bldpharm.com Catalog

The item is temporarily out of stock. Please leave your email address and we will inform you when we have it in stock.

How to Order

PRODUKT INFORMATION

Produktdetails
Sicherheit

Produkt Name :	Sodium 2-((R)-4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethanesulfonate hydrate
CAS Nr. :	110026-03-4	Molekulargewicht :	539.70
MDL Nr. :	MFCD00149238	Feinheit/Spezifikation :
Molekularformel :	C₂₆H₄₆NNaO₇S	Lagerung :	Keep in dark place,Inert atmosphere,Room temperature
Siedepunkt :	-

GHS Pictogram :
Signal Word :	Warning	Precautionary Statements :	P261-P280-P301+P312-P302+P352-P305+P351+P338
UN# :	N/A	Class :	N/A
Hazard Statements :	H302-H315-H319-H335	Packing Group :	N/A

Sodium 2-((R)-4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethanesulfonate hydrate *Cold-chain transportation

PRODUKT INFORMATION

ZUSAMMENHÄNGENDE PRODUKTE

HISTORISCHE AUFZEICHNUNGEN

Kontakt